
0:00
15:07
Cleaning validation fails in places nobody looked: the product nobody chose, the limit nobody calculated, the swab nobody recovered. Marcus and Priya work through the modern approach — worst-case product selection argued on paper, health-based PDE limits replacing inherited rules of thumb, the MACO carryover calculation step by step, and the sampling, recovery, and hold-time science that makes the numbers defensible.
• What cleaning validation must prove: the API is not the whole residue story — degradants, detergents, and bioburden included• The worst-case product: a scientific argument, not a vote — solubility, potency, cleanability, and the bracketing logic behind it• From dose rules to PDE: why the old one-thousandth-of-dose and ten-parts-per-million rules over-clean the easy and under-clean the potent• MACO walked through: previous product PDE, next batch size, maximum daily intake — and running it per product pair, not with one number for the building• Surface limits, the swab caveat, and recovery studies: why recovery below fifty percent suggests the method cannot find the residue• Dirty and clean hold times, campaign sizing, and verification versus validation in multipurpose facilities
New episodes every Monday and Wednesday — follow The GMP Insider so you never miss one.Connect with Tushar Arora on LinkedIn: https://www.linkedin.com/in/tushar-a-926382161Watch on YouTube: https://www.youtube.com/@TheGMPInsider
Produced with AI assistance.
• What cleaning validation must prove: the API is not the whole residue story — degradants, detergents, and bioburden included• The worst-case product: a scientific argument, not a vote — solubility, potency, cleanability, and the bracketing logic behind it• From dose rules to PDE: why the old one-thousandth-of-dose and ten-parts-per-million rules over-clean the easy and under-clean the potent• MACO walked through: previous product PDE, next batch size, maximum daily intake — and running it per product pair, not with one number for the building• Surface limits, the swab caveat, and recovery studies: why recovery below fifty percent suggests the method cannot find the residue• Dirty and clean hold times, campaign sizing, and verification versus validation in multipurpose facilities
New episodes every Monday and Wednesday — follow The GMP Insider so you never miss one.Connect with Tushar Arora on LinkedIn: https://www.linkedin.com/in/tushar-a-926382161Watch on YouTube: https://www.youtube.com/@TheGMPInsider
Produced with AI assistance.
Flere episoder fra "The GMP Insider"



Gå ikke glip af nogen episoder af “The GMP Insider” - abonnér på podcasten med gratisapp GetPodcast.








